Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Mar. 2024,
Elevance Health paid€521 Mil more to buy back shares than it received from issuing new shares.
It received€703 Mil from issuing more debt.
It paid€0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It spent€349 Mil paying cash dividends to shareholders.
It received€196 Mil on other financial activities.
In all, Elevance Healthearned€29 Mil on financial activities for the
three
months ended in Mar. 2024.
Elevance Health Cash Flow from Financing Historical Data
The historical data trend for Elevance Health's Cash Flow from Financing can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Elevance Health's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2,583 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elevance Health (WBO:ELV) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Elevance Health's issuance of stock for the
three
months ended in Mar. 2024 was €0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Elevance Health's repurchase of stock for the
three
months ended in Mar. 2024 was €-521 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Elevance Health's net issuance of debt for the
three
months ended in Mar. 2024 was €703 Mil.
Elevance Health received€703 Mil from issuing more debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Elevance Health's net issuance of preferred for the
three
months ended in Mar. 2024 was €0 Mil.
Elevance Health paid€0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Elevance Health's cash flow for dividends for the
three
months ended in Mar. 2024 was €-349 Mil.
Elevance Health spent€349 Mil paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Elevance Health's other financing for the
three
months ended in Mar. 2024 was €196 Mil.
Elevance Health received€196 Mil on other financial activities.
Elevance Health Cash Flow from Financing Related Terms
Thank you for viewing the detailed overview of Elevance Health's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WBO:ELV has been successfully added to your 